Generating molecules with protein models
Profluent develops AI systems for designing proteins, with applications in medicines, agriculture and industrial enzymes. Its contribution is both computational design and experimental testing of generated molecules, rather than a claim that a plausible protein sequence is automatically useful. [1][2]
An experimental gene editor becomes accessible
The OpenCRISPR-1 release published an AI-designed Cas9-like gene editor and compatible guide RNA. Profluent reported editing DNA in human cells. That establishes a laboratory demonstration and a research artifact, not an approved treatment or evidence of benefit in patients. [2][3]
The artifact and generator have different access
The repository makes the released molecular sequences available while distinguishing them from Profluent’s underlying generative models. Its FAQ requires a license agreement for commercial therapeutic uses and describes additional use conditions. Public sequence access therefore should not be read as an unrestricted software-style grant for every model or application. [3]
Sources
- Profluent
Profluent · retrieved Oct 23, 2026
- Editing the Human Genome with AI
Profluent · Apr 22, 2024
- Profluent-AI/OpenCRISPR
Profluent · retrieved Oct 23, 2026